Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MUU vs MRNA✓SelectedUSD · MRNAMUU vs MRNA performance historyLatest closeAs of-27.90%11/20
Stock and ETF performance explorer

MUU vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-61.9%
MRNA return
+323.5%
Excess return
-385.5%
Maximum drawdown
-84.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-27.9%-2.2%-25.7%-27.8%
7D-43.9%-12.7%-31.2%-43.6%
30D-63.2%-20.7%-42.6%-62.9%
3M-69.8%+46.3%-116.1%-69.6%
6M-61.9%+305.2%-367.1%-68.8%
All-61.9%+323.5%-385.5%-68.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling